{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreie2hv3ip47g7jieuxoxi2e4atpaszcvp3nxls2yzrclhzrykj7y34",
    "uri": "at://did:plc:eskrwciybv3pv2m4s34rimzk/app.bsky.feed.post/3mjwxccmvxre2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiek7ckdftdoguroyg3fe7ao6wyquvv6p4fuawux6ymrx7oi7qjnfy"
    },
    "mimeType": "image/jpeg",
    "size": 215377
  },
  "path": "/news/daewoong-hadirkan-fexuprazan-di-indonesia-solusi-terbaru-atasi-asam-lambung",
  "publishedAt": "2026-04-20T16:43:00.000Z",
  "site": "https://www.jpnn.com",
  "tags": [
    "News",
    "Lifestyle",
    "Daewoong"
  ],
  "textContent": "**JPNN.com** , JAKARTA - Daewoong Pharmaceutical Indonesia (Daewoong) secara resmi mengumumkan bahwa obat inovatif mereka, Fexuprazan 40 mg, telah mendapatkan izin edar dari Badan Pengawas Obat dan Makanan Republik Indonesia (BPOM).",
  "title": "Daewoong Hadirkan Fexuprazan di Indonesia, Solusi Terbaru Atasi Asam Lambung"
}